Variant report
Variant | nsv9434 |
---|---|
Chromosome Location | chr16:30331545-30333072 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs377766711 | chr16:30331547-30331548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs573098993 | chr16:30331678-30331679 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs542864177 | chr16:30331700-30331701 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529085600 | chr16:30331715-30331716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs561254128 | chr16:30331717-30331718 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs8048666 | chr16:30331730-30331731 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs547217232 | chr16:30331800-30331801 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs565615707 | chr16:30331808-30331809 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555547609 | chr16:30331831-30331832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs182611119 | chr16:30331837-30331838 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs565680722 | chr16:30331876-30331877 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs148907194 | chr16:30331893-30331894 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs200683212 | chr16:30331945-30331946 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs200540860 | chr16:30332011-30332012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs35195530 | chr16:30332022-30332023 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537053406 | chr16:30332088-30332089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs150656850 | chr16:30332128-30332129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs374986868 | chr16:30332131-30332132 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs367636450 | chr16:30332132-30332133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs139114503 | chr16:30332144-30332145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs372130209 | chr16:30332201-30332202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs34876189 | chr16:30332203-30332204 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs553169758 | chr16:30332232-30332233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs375165332 | chr16:30332249-30332250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs577780760 | chr16:30332301-30332302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs538716928 | chr16:30332302-30332303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs557035855 | chr16:30332366-30332367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs575195273 | chr16:30332376-30332377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562876760 | chr16:30332387-30332388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561419729 | chr16:30332469-30332470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs34778363 | chr16:30332473-30332474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573507503 | chr16:30332514-30332515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs74328793 | chr16:30332522-30332523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs11442194 | chr16:30332570-30332571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs200347039 | chr16:30332586-30332587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs34355807 | chr16:30332588-30332589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565441947 | chr16:30332617-30332618 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs545477489 | chr16:30332653-30332654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532601335 | chr16:30332752-30332753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs551455372 | chr16:30332769-30332770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563414501 | chr16:30332780-30332781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs560618913 | chr16:30332801-30332802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs374601234 | chr16:30332812-30332813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs549029588 | chr16:30332844-30332845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 20651079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 16608533 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 22566537 | CNVD |
Intellectual disability | 22566537 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Lung cancer | 18438408 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Mental retardation | 19951919 | CNVD |
Colorectal cancer | 16272173 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bladder cancer | 21909424 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21785460 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21990379 | CNVD |
Astrocytoma | 22246337 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Epilepsy | 22499536 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22513405 | CNVD |
Autism | 22958593 | CNVD |
Autism | 18184952 | CNVD |
Autism | 19966786 | CNVD |
Autism | 21394203 | CNVD |
Autism | 21969575 | CNVD |
Autism | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Autism | 20942916 | CNVD |
Epilepsy | 20970697 | CNVD |
Intellectual disability | 22045946 | CNVD |
Mental retardation | 19966786 | CNVD |
Developmental delay | 20808231 | CNVD |
Obesity | 20808231 | CNVD |
Autism | 18923514 | CNVD |
Obesity | 21881559 | CNVD |
Obesity | 21956041 | CNVD |
Autism | 20659124 | CNVD |
Mental retardation | 21062444 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 21285140 | CNVD |
Schizophrenia | 22885689 | CNVD |
Schizophrenia | 20553308 | CNVD |
Schizophrenia | 20970697 | CNVD |
Schizophrenia | 20433910 | CNVD |
Schizophrenia | 22241247 | CNVD |
Autism | 19242545 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Schizophrenia | 21399695 | CNVD |
Autism | 21956041 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Autism | 22067053 | CNVD |
Autism | 18156158 | CNVD |
Mental retardation | 20152051 | CNVD |
Autism | 19218893 | CNVD |
Autism | 21289514 | CNVD |
Schizophrenia | 19855392 | CNVD |
neurodevelopmental Syndrome | 20503337 | CNVD |
Benign familial neonatal-infantile seizures | 21060786 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Cancer | 21183584 | CNVD |
Low-grade fibromyxoid sarcoma | 21536545 | CNVD |
Breast cancer | 21045282 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Autism | 19050728 | CNVD |
Epilepsy | 20923578 | CNVD |
Psychiatric disorder | 19050728 | CNVD |
Schizophrenia | 19348701 | CNVD |
Attention deficit hyperactivity disorder | 19097825 | CNVD |
Autism | 20964600 | CNVD |
Schizophrenia | 19955444 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 19571808 | CNVD |
Breast cancer | 20409316 | CNVD |
Severe combined immunodeficiency | 19097825 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Autism | 18522746 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:30286000-30345400 | Weak transcription | Fetal Stomach | stomach |
2 | chr16:30288600-30338400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr16:30306000-30344800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr16:30310400-30336200 | Weak transcription | Fetal Thymus | thymus |
5 | chr16:30310400-30338600 | Weak transcription | Left Ventricle | heart |
6 | chr16:30320400-30335800 | Weak transcription | Primary B cells from cord blood | blood |
7 | chr16:30320400-30345200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
8 | chr16:30320600-30336200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
9 | chr16:30320800-30332000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr16:30320800-30335400 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
11 | chr16:30320800-30336200 | Weak transcription | Primary B cells from peripheral blood | blood |
12 | chr16:30321000-30336400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
13 | chr16:30324200-30345600 | Weak transcription | Thymus | Thymus |
14 | chr16:30325800-30345800 | Weak transcription | Primary T killer memory cells from peripheral blood | blood |
15 | chr16:30326800-30345800 | Weak transcription | Lung | lung |
16 | chr16:30328200-30341600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
17 | chr16:30328600-30331600 | Weak transcription | K562 | blood |
18 | chr16:30329200-30345200 | Weak transcription | Fetal Intestine Small | intestine |
19 | chr16:30329600-30345400 | Weak transcription | Primary T cells fromperipheralblood | blood |
20 | chr16:30331000-30344800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr16:30331600-30332200 | Enhancers | K562 | blood |
22 | chr16:30332000-30332200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
23 | chr16:30332200-30345200 | Weak transcription | Monocytes-CD14+_RO01746 | blood |